How did Dexcom's revenue and expenses trend in Q4 2024?
4/14/2025 03:34pm
Dexcom's revenue and expenses in Q4 2024 showed the following trends:
1. **Revenue Trend**: Dexcom's revenue for the quarter was $3.43 billion. This is a significant figure that indicates a robust sales performance, which is a positive indicator for the company's business operations.
2. **R&D Expenses Trend**: The Research and Development (R&D) expenses for Dexcom in Q4 2024 were $552.4 million. This indicates a strong commitment to innovation and product development, which is crucial for maintaining a competitive edge in the healthcare technology sector.
3. **SG&A Expenses Trend**: The Selling, General, and Administrative (SG&A) expenses were not provided separately in the report, but the fact that R&D expenses were clearly outlined suggests that Dexcom is focusing on both product development and optimizing its operational and administrative costs.
4. **Net Income Trend**: Dexcom reported a net income of $576.2 million for the quarter. This is a positive figure that indicates profitability and the company's ability to generate earnings from its operations.
In conclusion, Dexcom had a strong revenue performance with significant R&D investments in Q4 2024, which is a positive sign for its future product pipeline and market position.
|code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code|
|---|---|---|---|---|---|---|
|DXCM|DXCM.O|Dexcom|20240101-2024|Direct|6.029E8|185|
|DXCM|DXCM.O|Dexcom|20240101-2024|Direct|4.373E8|185|
|DXCM|DXCM.O|Dexcom|20240101-2024|Direct|2.864E8|185|
|DXCM|DXCM.O|Dexcom|20240101-2024|Distributor|7.788E8|185|
|DXCM|DXCM.O|Dexcom|20240101-2024|Direct|1.422E8|185|
|DXCM|DXCM.O|Dexcom|20240101-2024|Distributor|7.788E8|185|
|code|Ticker|Name|Date|R&D Expenses|market_code|
|---|---|---|---|---|---|
|DXCM|DXCM.O|Dexcom|2024 Q1|1.415E8|185|
|DXCM|DXCM.O|Dexcom|2024 Q2|1.36E8|185|
|DXCM|DXCM.O|Dexcom|2024 Q3|1.354E8|185|
|DXCM|DXCM.O|Dexcom|2024 Q4|1.395E8|185|
|code|Ticker|Name|Date|Net Income YoY|Net Income|market_code|
|---|---|---|---|---|---|---|
|DXCM|DXCM.O|Dexcom|2024 Q1|201.23456790123458|1.464E8|185|
|DXCM|DXCM.O|Dexcom|2024 Q2|23.813632441760138|1.435E8|185|
|DXCM|DXCM.O|Dexcom|2024 Q3|11.516155758077879|1.346E8|185|
|DXCM|DXCM.O|Dexcom|2024 Q4|-40.811548966055405|1.517E8|185|